“Simpsons” actor Hank Azaria sues Craig Bierko over character right

LOS ANGELES (TheWrap.com) – Hank Azaria, who provides the voices for a host of characters on “The Simpsons,” including Moe Szyslak and Chief Wiggum, is suing over the rights to one of his characters.

Azaria and his How to Pictures, Inc. filed suit Wednesday against “Leap Year” actor Craig Bierko in U.S. District Court in Central California on Wednesday, saying that Bierko is jeopardizing a potential movie deal by falsely laying claim to a voice that Azaria claims he created nearly 30 years ago.

Don’t worry, though; Springfield’s favorite curmudgeonly bartender and inept police chief won’t be affected.

According to the suit, Azaria created a voice for a “a colorful baseball announcer who speaks with peculiar speech inflections” in 1983 or beforehand, and introduced the voice to Bierko after meeting him in 1990.

In 2010, Azaria used the voice in a Funny or Die skit in which he played a sportscaster named Jim Brockmire, which employed the voice in question. (The suit also notes that the Brockmire character employed other attributes, such as a plaid jacket and a back story about his wife abandoning him.)

The video became a hit, the lawsuit says – so much so that Azaria was able “to entertain discussions to develop a feature-length motion picture based upon the Jim Brockmire Character who uses the Azaria Voice.”

It also drew the attention of Bierko, who subsequently contacted Azaria and claimed to have created the voice either independently or in collaboration with Azaria, the suit says. (The complaint says that Bierko never made clear which it was, and that Azaria denies the claim in either case.)

The suit claims that Bierko’s claim to ownership on the voice “has created a cloud over the rightful ownership of the Azaria Voice (which is an integral part of the Jim Brockmire Character) such that Plaintiffs’ ability to develop a feature length motion picture based upon the Jim Brockmire Character is being significantly impeded.”

A representative for Bierko has not yet responded to TheWrap’s request for comment.

Azaria is seeking a declaration that the sportscaster voice alone isn’t copyrightable, but that the Brockmire character is, plus a declaration that Bierko as no claim to the voice. (He also wants Bierko blocked from laying claim to the voice.)

The suit also asks for attorney’s fees and court costs.

(Pamela Chelin contributed to this report)

TV News Headlines – Yahoo! News

Read More..

The Neediest Cases: Emerging From a Bleak Life to Become Fabulous Phil

For years, Phillip Johnson was caught in what seemed like an endless trench of bad luck. He was fired from a job, experienced intensifying psychological problems, lost his apartment and spent time in homeless shelters. At one point, he was hospitalized after overdosing on an antipsychotic drug.

“I had a rough road,” he said.

Since his hospital stay two years ago, and despite setbacks, Mr. Johnson, 27, has been getting his life on track. At Brooklyn Community Services, where he goes for daily counseling and therapy, everybody knows him as Fabulous Phil.

“Phillip is a light, the way he evokes happiness in other people,” his former caseworker, Teresa O’Brien, said. “Phillip’s character led directly to his nickname.”

About six months ago, with Ms. O’Brien’s help, Mr. Johnson started an event: Fabulous Phil Friday Dance Party Fridays.

One recent afternoon at the agency, 30 clients and a few counselors were eating cake, drinking soft drinks and juice, and grooving for 45 minutes to Jay-Z and Drake pulsating from a boom box.

Mr. Johnson’s voice rose with excitement when he talked about the party. Clients and counselors, he said, “enjoy themselves.”

“They connect more; they communicate more,” he continued. “Everybody is celebrating and laughing.”

The leadership Mr. Johnson now displays seems to be a far cry from the excruciatingly introverted person he was.

As an only child living with his single mother in public housing in Bedford-Stuyvesant, Brooklyn, he said, he tended to isolate himself. “A lot of kids my age would say, ‘Come outside,’ but I would always stay in my room,” he said. He occupied himself by writing comic books or reading them, his favorites being Batman and Spiderman because, he said, “they were heroes who saved the day.”

After graduating from high school in 2003, he worked odd jobs until 2006, when he took a full-time position at a food court at La Guardia Airport, where he helped to clean up. The steady paycheck allowed him to leave his mother’s apartment and rent a room in Queens.

But the depression and bleak moods that had shadowed him throughout middle and high school asserted themselves.

“My thinking got confused,” he said. “Racing thoughts through my mind. Disorganized thoughts. I had a hard time focusing on one thing.”

In 2008, after two years on the job, Mr. Johnson was fired for loud and inappropriate behavior, and for being “unpredictable,” he said. The boss said he needed counseling. He moved back in with his mother, and in 2009 entered a program at an outpatient addiction treatment service, Bridge Back to Life. It was there, he said, that he received a diagnosis of schizophrenia and help with his depression and marijuana use.

But one evening in May 2010, he had a bout with insomnia.

He realized the antipsychotic medication he had been prescribed, Risperdal, made him feel tired, he said, so he took 12 of the pills, rather than his usual dosage of two pills twice a day. When 12 did not work, he took 6 more.

“The next morning when I woke up, it was hard for me to breathe,” he said.

He called an ambulance, which took to Woodhull Hospital. He was released after about a month.

Not long after, he returned to his mother’s apartment, but by February 2011, they both decided he should leave, and he relocated to a homeless shelter in East New York, where, he said, eight other people were crammed into his cubicle and there were “bedbugs, people lying in your bed, breaking into your locker to steal your stuff.”

In late spring 2011, he found a room for rent in Manhattan, but by Thanksgiving he was hospitalized again. Another stint in a shelter followed in April, when his building was sold.

Finally, in July, Mr. Johnson moved to supported housing on Staten Island, where he lives with a roommate. His monthly $900 Social Security disability check is sent to the residence, which deducts $600 for rent and gives him $175 in spending money; he has breakfast and lunch at the Brooklyn agency. To assist Mr. Johnson with unexpected expenses, a grant of $550 through The New York Times Neediest Cases Fund went to buy him a bed and pay a Medicare prescription plan fee for three months.

“I was so happy I have a bed to sleep on,” he said about the replacement for an air mattress. “When I have a long day, I have a bed to lay in, and I feel good about that.”

Mr. Johnson’s goals include getting his driver’s license — “I already have a learner’s permit,” he said, proudly — finishing his program at the agency, and then entering an apprenticeship program to become a plumber, carpenter or mechanic.

But seeing how his peers have benefited from Fabulous Phil Fridays has made him vow to remain involved with people dealing with mental illnesses or substance abuse.

He was asked at the party: Might he be like the comic-book heroes he loves? A smile spread across his face. He seemed to think so.

Read More..

Former O.C. Sheriff Michael Carona seeks to cut prison sentence

Attorneys for former Orange County Sheriff Michael Carona — who is now serving 66 months in federal prison for witness tampering — are asking that the former lawman's sentence be cut by nearly half, potentially freeing him.

In a motion, Carona's attorneys argued that the sentence handed down in 2009 by U.S. District Judge Andrew Guilford should be adjusted after changes in the law.

His attorneys contend that the judge sentenced Carona on the witness tampering charge by "cross-referencing" charges on which he was acquitted, a practice his attorneys argue that the U.S. Supreme Court overruled in a case involving former Enron President Jeffrey Skilling.

"Carona seeks relief on the ground that the court erred in determining his sentence by using honest services fraud as the 'underlying offense' under United States sentencing guidelines," his lawyers wrote in the motion filed earlier this month. They added that "the conduct at issue did not constitute honest services fraud or any other federal offense."

His lawyers, according to the motion, are seeking to reduce his time to a term of 24 months to 30 months.

Brett Sagel, the federal prosecutor on the case, said in an emailed statement Thursday that the government contends "Carona's filing lacks merit both factually and legally."

Carona was acquitted in 2009 on charges of conspiracy, mail fraud and one count of witness tampering. But the jury found him guilty on another count of witness tampering after he was recorded as he tried to persuade his former assistant sheriff to lie to a grand jury investigating allegations of corruption.

Carona, 57, was widely considered to be a rising political star at the time of his indictment.

The former sheriff began serving his 51/2 -year prison sentence in January 2011 at Englewood Federal Correctional Institution in Littleton, Colo., where he joined other prominent criminals — including Skilling, who is serving a 24-year sentence; and disgraced former Illinois Gov. Rod Blagojevich.

When Carona's sentence began, officials at the prison — dubbed by Forbes magazine as one of the "12 best places to go to prison" — said the former sheriff would put in 71/2-hour days doing landscaping, plumbing, painting or food service.

But he could have access to the low-security prison's amenities, including college courses and the use of indoor and outdoor recreational facilities with a running track, bicycle court and exercise bicycles.

Carona's lawyers said that he had exhausted his appeals when the U.S. 9th Circuit Court of Appeals upheld his conviction shortly before he reported to the prison.

rick.rojas@latimes.com

Read More..

10 Sci-Fi Weapons That Actually Exist

Sure, the gear may look like it came straight out of Avatar or Battlestar Galactica. But all of the laser weapons, robots, sonic blasters and puke rays pictured here are real. Some of these weapons have already found their way onto the battlefield. If the rest of this sci-fi arsenal follows, war may soon be unrecognizable.

Read on for a look at some of these futuristic weapons being tested today.

Above:

The XM-25 grenade launcher is equipped with a laser rangefinder and on-board computer. It packs a magazine of four 25mm projectiles, and programs them to detonate as they pass by their targets. That feature will allow soldiers to strike enemies who are taking cover. By 2012, the Army hopes to arm every infantry squad and Special Forces unit with at least one of the big guns.

In August, a lucky soldier got to pull the trigger, and fire off a HEAB, or High Explosive Air Burst, round at the Aberdeen Testing Ground in Maryland. Those projectiles pack quite a punch. They are purportedly 300 percent more effective than normal ammo, and will be able to strike targets as far as 700 meters (2,300 feet) away.

Photo courtesy U.S. Army

Pages: 1 2 3 4 5 6 7 8 9 10 View All

Read More..

Final “Twilight” dawns with $30 million from late-night shows

LOS ANGELES (Reuters) – Bella and Edward’s big-screen farewell lit up box offices with $ 30.4 million in late-night ticket sales for the finale of the blockbuster “Twilight” vampire series, production studio Summit Entertainment said on Friday.

The U.S. and Canadian box office receipts for “The Twilight Saga: Breaking Dawn, Part 2″ beat initial sales for each of the previous four films in the franchise, though the final installment got a boost from late Thursday night previews.

Last year’s “Breaking Dawn, Part 1″ kicked off with $ 30.3 million from shows just after midnight on the Friday that it debuted, according to figures from Hollywood.com. Summit, a unit of Lions Gate Entertainment Corp, did not provide Friday-only numbers for “Breaking Dawn, Part 2.”

The record for opening-night sales belongs to “Harry Potter and the Deathly Hallows, Part 2,” the finale in the boy-wizard series that grabbed $ 43.5 million when it debuted in July 2011.

Box office watchers say the “Twilight” finale has a shot at setting the franchise record for opening weekend sales when receipts through Sunday are tallied. “The Twilight Saga: New Moon,” released in November 2009, now ranks as the biggest opening in the series, with $ 142.8 million in sales over the first three days after its release in November 2009.

“Breaking Dawn – Part 2″ stars Kristen Stewart, Robert Pattinson and Taylor Lautner in the conclusion of angst-ridden vampire and werewolf love triangle created by author Stephenie Meyer in a series of young adult books. In the final film, wedded vampires Bella and Edward must protect their daughter from an ancient vampire clan.

Opening weekend will get a lift from fans who rush out to see the movie because it is the last film in the popular series, said Paul Dergarabedian, president of the box office division of Hollywood.com. He projects domestic three-day sales will reach $ 145 million to $ 150 million.

“Like ‘Potter,’ the final installment of this will benefit from the cachet of being the last one,” he said.

(Reporting By Lisa Richwine; editing by Andrew Hay)

Movies News Headlines – Yahoo! News

Read More..

Drug Shortages Are Becoming Persistent in U.S.

Paul Davis, the chief of a rural ambulance squad in southern Ohio, was down to his last vial of morphine earlier this fall when a woman with a broken leg needed a ride to the hospital.

The trip was 30 minutes, and the patient was in pain. But because of a nationwide shortage, his morphine supply had dwindled from four doses to just one, presenting Mr. Davis with a stark quandary. Should he treat the woman, who was clearly suffering? Or should he save it for a patient who might need it more?

In the end, he opted not to give her the morphine, a decision that haunts him still. “I just feel like I’m not doing my job,” said Mr. Davis, who is chief of the rescue squad in Vernon, Ohio. He has since refilled his supply. “I shouldn’t have to make those kinds of decisions.”

From rural ambulance squads to prestigious hospitals, health care workers are struggling to keep vital medicines in stock because of a drug shortage crisis that is proving to be stubbornly difficult to fix. Rationing is just one example of the extraordinary lengths being taken to address the shortage, which health care workers say has ceased to be a temporary emergency and is now a fact of life. In desperation, they are resorting to treating patients with less effective alternative medicines and using expired drugs. The Cleveland Clinic has hired a pharmacist whose only job is to track down hard-to-find drugs.

Caused largely by an array of manufacturing problems, the shortage has prompted Congressional hearings, a presidential order and pledges by generic drug makers to communicate better with federal regulators.

The problem peaked in 2011, when a record 251 drugs were declared in short supply. This year, slightly more than 100 were placed on the list, and workers say the battle to keep pharmacy shelves stocked continues unabated. The list of hard-to-find medicines ranges from basic drugs like the heart medicine nitroglycerin to a lidocaine injection, which is used to numb tissue before surgery.

A deadly meningitis outbreak caused by contamination at a large drug producer could worsen the situation, federal officials have warned. The Food and Drug Administration said that shortages of six drugs — medicines used during surgery and to treat conditions like congestive heart failure — could get worse after a big compounding pharmacy closed over concerns about drug safety. The pharmacy, Ameridose, shares some management with the New England Compounding Center, which is at the center of a meningitis outbreak that has claimed 33 lives.

“When you can’t treat basic things — cardiac arrest, pain management, seizures — you’re in trouble,” said Dr. Carol Cunningham, the state medical director for the Ohio Department of Public Safety’s emergency services division. “When you only have five tools in your toolbox and three of them are gone, what do you do?”

Dr. Margaret A. Hamburg, the F.D.A. commissioner, said in an interview this week that she was “guardedly optimistic” that the shortage crisis was abating. “I think there’s been an enormous amount of progress,” she said. “We’re seeing real change in the number of shortages that we’re able to recognize early.” More than 150 new shortages have been prevented this year, according to the agency.

But Erin Fox, who tracks supply levels for a broader range of drugs at the University of Utah, said once a drug became scarce, it tended to stay scarce. The university’s Drug Information Service was actively tracking 282 hard-to-find products by the end of the third quarter of this year, a record.

“The shortages we have aren’t going away — they’re not resolving,” she said. “But the good news is we’re not piling more shortages on top.”

In 2011, prompted by emotional pleas by cancer patients and others who said the drug shortage was threatening lives, President Obama issued an executive order requiring drug makers to notify the F.D.A. when a shortage appeared imminent. The agency also loosened some restrictions on importing drugs, and sped up approvals by other manufacturers to make certain medicines.

A law passed this summer contains several provisions aimed at improving the situation, including expediting approval of new generic medicines and requiring the agency’s enforcement unit to better coordinate with its drug-shortage officials before it takes action against a manufacturer.

Ralph G. Neas, the chief executive of the Generic Pharmaceutical Association, said fixing the drug shortage was complex and would take time, but was a top priority. “One shortage is one shortage too many,” he said. “One patient not getting a critical drug is one patient too many.”

Federal drug officials trace much of the drug shortage crisis to delays at plants that make sterile injectable drugs, which account for about 80 percent of the scarce medicines. Nearly a third of the industry’s manufacturing capacity is not running because of plant closings or shutdowns to fix serious quality issues. Other shortages have been caused by supply disruptions of the raw ingredients used to make the drugs, or by manufacturers exiting the market.

Read More..

Drug Shortages Are Becoming Persistent in U.S.

Paul Davis, the chief of a rural ambulance squad in southern Ohio, was down to his last vial of morphine earlier this fall when a woman with a broken leg needed a ride to the hospital.

The trip was 30 minutes, and the patient was in pain. But because of a nationwide shortage, his morphine supply had dwindled from four doses to just one, presenting Mr. Davis with a stark quandary. Should he treat the woman, who was clearly suffering? Or should he save it for a patient who might need it more?

In the end, he opted not to give her the morphine, a decision that haunts him still. “I just feel like I’m not doing my job,” said Mr. Davis, who is chief of the rescue squad in Vernon, Ohio. He has since refilled his supply. “I shouldn’t have to make those kinds of decisions.”

From rural ambulance squads to prestigious hospitals, health care workers are struggling to keep vital medicines in stock because of a drug shortage crisis that is proving to be stubbornly difficult to fix. Rationing is just one example of the extraordinary lengths being taken to address the shortage, which health care workers say has ceased to be a temporary emergency and is now a fact of life. In desperation, they are resorting to treating patients with less effective alternative medicines and using expired drugs. The Cleveland Clinic has hired a pharmacist whose only job is to track down hard-to-find drugs.

Caused largely by an array of manufacturing problems, the shortage has prompted Congressional hearings, a presidential order and pledges by generic drug makers to communicate better with federal regulators.

The problem peaked in 2011, when a record 251 drugs were declared in short supply. This year, slightly more than 100 were placed on the list, and workers say the battle to keep pharmacy shelves stocked continues unabated. The list of hard-to-find medicines ranges from basic drugs like the heart medicine nitroglycerin to a lidocaine injection, which is used to numb tissue before surgery.

A deadly meningitis outbreak caused by contamination at a large drug producer could worsen the situation, federal officials have warned. The Food and Drug Administration said that shortages of six drugs — medicines used during surgery and to treat conditions like congestive heart failure — could get worse after a big compounding pharmacy closed over concerns about drug safety. The pharmacy, Ameridose, shares some management with the New England Compounding Center, which is at the center of a meningitis outbreak that has claimed 33 lives.

“When you can’t treat basic things — cardiac arrest, pain management, seizures — you’re in trouble,” said Dr. Carol Cunningham, the state medical director for the Ohio Department of Public Safety’s emergency services division. “When you only have five tools in your toolbox and three of them are gone, what do you do?”

Dr. Margaret A. Hamburg, the F.D.A. commissioner, said in an interview this week that she was “guardedly optimistic” that the shortage crisis was abating. “I think there’s been an enormous amount of progress,” she said. “We’re seeing real change in the number of shortages that we’re able to recognize early.” More than 150 new shortages have been prevented this year, according to the agency.

But Erin Fox, who tracks supply levels for a broader range of drugs at the University of Utah, said once a drug became scarce, it tended to stay scarce. The university’s Drug Information Service was actively tracking 282 hard-to-find products by the end of the third quarter of this year, a record.

“The shortages we have aren’t going away — they’re not resolving,” she said. “But the good news is we’re not piling more shortages on top.”

In 2011, prompted by emotional pleas by cancer patients and others who said the drug shortage was threatening lives, President Obama issued an executive order requiring drug makers to notify the F.D.A. when a shortage appeared imminent. The agency also loosened some restrictions on importing drugs, and sped up approvals by other manufacturers to make certain medicines.

A law passed this summer contains several provisions aimed at improving the situation, including expediting approval of new generic medicines and requiring the agency’s enforcement unit to better coordinate with its drug-shortage officials before it takes action against a manufacturer.

Ralph G. Neas, the chief executive of the Generic Pharmaceutical Association, said fixing the drug shortage was complex and would take time, but was a top priority. “One shortage is one shortage too many,” he said. “One patient not getting a critical drug is one patient too many.”

Federal drug officials trace much of the drug shortage crisis to delays at plants that make sterile injectable drugs, which account for about 80 percent of the scarce medicines. Nearly a third of the industry’s manufacturing capacity is not running because of plant closings or shutdowns to fix serious quality issues. Other shortages have been caused by supply disruptions of the raw ingredients used to make the drugs, or by manufacturers exiting the market.

Read More..

FHA projected to exhaust reserves, could need bailout

WASHINGTON -- The Federal Housing Administration, which has played a crucial role in stabilizing the housing market, said it ended September with $16.3 billion in projected losses -- a possible prelude to a taxpayer bailout.

The precarious financial situation could force the FHA, which has been self-funded through mortgage insurance premiums since it was created during the Great Depression, to tap the U.S. Treasury to stay afloat.

The agency said a determination on whether it needs a bailout won't come until next year.

The FHA is required to maintain enough cash reserves to cover losses on the mortgages it insures. But in its annual actuarial report to Congress, the agency said a slower-than-anticipated housing market recovery has led its reserves to fall $16.3 billion below anticipated losses.

The FHA's cash reserves aren't supposed to drop below 2% of projected losses. They ended the 2012 fiscal year at -1.44%, down from the seriously low level of 0.24% at the end of 2011.

Quiz: How much do you know about the 'fiscal cliff'?

The FHA and the Department of Housing and Urban Development, which oversees it, said the report "does not mean FHA has insufficient cash to pay insurance claims, a current operating deficit or will need to immediately draw funds from the Treasury."

A request for taxpayer money would come in President Obama's 2014 budget, set to be released in February, with a final determination of whether the FHA needs the funds coming next September. The FHA has permanent and indefinite authority to draw money from the Treasury, although it has never had to use that power.

The FHA does not lend money, but guarantees loans made by banks in exchange for insurance premiums. The agency's role has expanded since the crash of the subprime mortgage market, and it now insures about $1.1 trillion in loans, according to Inside Mortgage Finance.

But the expanded role, including backing mortgages with as little as 3.5% down payment and for some people who have undergone recent foreclosures, has taken a toll on its finances. The agency boosted premiums and took other steps in 2009 to shore up its capital reserves.

"While the loans made during this administration remain the strongest in the agency's history, we take the findings of the independent actuary very seriously," said acting FHA Commissioner Carol Galante. "We will continue to take aggressive steps to protect FHA's financial health while ensuring that FHA continues to perform its historic role of providing access to homeownership for underserved communities and supporting the housing market during tough economic times."

[For the Record, 5:13 a.m. Nov. 16: A previous version of this post referred to the FHA as the Federal Housing Agency. It is the Federal Housing Administration.]

ALSO:

Obama slashes fees on FHA-backed mortgages

FHA could need taxpayer bailout next year, report says

FHA gives those who defaulted on homes another chance

Follow Jim Puzzanghera on Twitter and Google+.

Read More..

Russia's Stealth Fighter Could Match U.S. Jets, Analyst Says

Russia’s T-50 stealth fighter prototype, the first radar-evading warplane outside the U.S. when it debuted in January 2010, is slightly less stealthy than the American F-22 and about equal to the smaller F-35. But in several other respects the new warplane from the Russian Sukhoi design bureau is actually superior to the American models.

That’s the surprising conclusion of the first-ever public scientific analysis of the T-50′s Radar Cross-Section (RCS), completed this week by Dr. Carlo Kopp, an analyst with the independent think tank Air Power Australia.

“The shaping of the T-50 is inferior to that of the F-22 Raptor,” Kopp writes in his dense, jargon-heavy report. But the F-35 and T-50, he adds, exhibit “similar … RCS behavior.”

But Kopp’s assessment of the T-50 comes with caveats. Quite a few of them, actually. To match the stealthiness of the Lockheed Martin F-35 — to say nothing of the company’s F-22 — Sukhoi’s engineers will have to, among other changes, modify the T-50′s engines to a less obtrusive fitting and add a layer of radar-absorbing material to the plane’s skin.

With the revised engines and skin, the T-50′s “specular RCS performance will satisfy the Very Low Observable (VLO) requirement that strong specular returns are absent in the nose sector angular domain,” Kopp writes. Translated into plain English, Kopp’s saying that an optimized version of the Russian jet could be very, very difficult to detect by most radars as it’s bearing down on them.

Major refinements are standard practice as stealth prototypes go through development, it’s worth noting. The F-22 and the F-35 underwent big design changes as each was developed over 15 years or more. The T-50, only four of which have been built, has been flying for just under three years and isn’t scheduled to enter frontline service until 2016 at the earliest. There’s time for the Russians to finesse the design, just as the Chinese are doing with their stealth planes.

Granted, by 2016 the Americans could possess hundreds of combat-ready F-35s plus the roughly 180 F-22s already in service. The T-50 could make up for its lateness with impressive performance that in some ways exceeds even the F-22′s vaunted capabilities.

One Russian advantage is what Kopp calls “extreme plus agility” — a consequence of the T-50′s “advanced aerodynamic design, exceptional thrust/weight ratio performance and three dimensional thrust vectoring integrated with an advanced digital flight control system.”

The second advantage: “exceptional combat persistence, the result of an unusually large 25,000-pound internal fuel load,” Kopp writes. The T-50 could keep flying and fighting long after the F-22 and F-35 have run out of gas.

Moreover, the T-50 will dodge certain radars better than others, according to Kopp — and U.S. sensors are among the worst at detecting the T-50′s unique shape, he contends. Kopp’s breakdown of T-50 RCS by radar type shows Chinese “counter-VLO radars,” specifically designed to spot American stealth planes, detecting the T-50 best.

The next best sensors to use against the Russian fighter is the UHF radar aboard the U.S. Navy’s E-2 early-warning planes. American fighter radars, including those aboard the F-22 and F-35, are of middling effectiveness against the T-50, Kopp asserts.

“No fundamental obstacles exist in the shaping design of the T-50 prototype which might preclude its development into a genuine Very Low Observable design,” Kopp concludes.

In other words: Watch out, America! You’re now only one of three countries with a truly radar-evading warplane in the air.

Read More..

Juanes, Jesse & Joy take home top Latin Grammys

LAS VEGAS (Reuters) – Colombian rocker Juanes and the Mexican brother and sister pop duo Jesse & Joy took home the top Latin Grammys on Thursday in Las Vegas on a night in which the contemporary triumphed over the traditional.

Juanes, one of the most well known Latin American stars worldwide, won the coveted album of the year with his “MTV Unplugged,” which also won best long-form video. Dominican singer and songwriter Juan Luis Guerra won producer of the year for Juanes‘ album.

“Here’s to the maestro Juan Luis Guerra for making this possible,” said Juanes, 40, who now has won 19 Latin Grammys, tying him with reggaeton group Calle 13 for the most awards.

Guerra, who made the romantic Bachata music famous and is known to sweep the awards from the Latin Academy of Recording Arts and Sciences, led the nominations with six nods this year. But he lost out on the big awards for record and song of the year with his “En El Cielo No Hay Hospital” (In Heaven There Is No Hospital).

Those two awards went to “Corre!” (Run!) by Jesse & Joy, the duo from Mexico City who won best new artists in the same Las Vegas venue in 2007. Their third studio album Con Quien Se Queda El Perro? (Who Is The Dog Staying With?) lost out on album of the year, but won best contemporary pop vocal album.

“Viva Mexico!,” said Jesse upon accepting record of the year, a phrase repeated several times by winners at the 13th edition of the Latin Grammys Thursday night.

Like Jesse & Joy five years earlier, Mexican pop group 3BallMTY won best new artists with their musical style known as “tribal guarachero,” a mix of Mexican cumbia and electronic dance music.

The trio, barely beyond their teenage years, found success on both sides of the U.S.-Mexico border with their debut album “Intentalo” (Try It). They dedicated their Latin Grammy to Mexican DJs.

Mexico’s Carla Morrison won best alternative music album with “Dejenme Llorar” (Let Me Cry). Wearing a red dress and sporting multiple tattoos on her arms, she let loose an expletive on the live broadcast after crying out “Viva Mexico!”

Among the top performances of the night were Juanes playing with veteran guitarrist Carlos Santana. The show opened with Miami-born rapper Pitbull, who sings in both English and Spanish.

Brazilian singer and songwriter Caetano Veloso was honored as the Latin Recording Academy‘s person of the year in a ceremony on Wednesday. A founder of the 1960s musical movement known as Tropicalia, Veloso continues to to be one of Brazil’s most popular and innovative artists at 70 years of age.

(Writing by Mary Milliken; Editing by Lisa Shumaker)

Music News Headlines – Yahoo! News

Read More..